EUVIMEDEUVIMED entdecken
Crossref

Enteral, Oral, and Rectal Absorption of Ceftriaxone Using Glyceride Enhancers

G Beskid, J Unowsky, C R Behl, J Siebelist, J L Tossounian, C M McGarry, N H Shah, R Cleeland

Chemotherapy · 09.09.2009 · 77-84

DOI: 10.1159/000238551 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemotherapy, online erschienen am 09.09.2009. Verfasst von G Beskid und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Hoffmann-La Roche Inc., Nutley, N.J. Hauptthemen laut MEDLINE: Intestinal Absorption. Die Arbeit wurde bisher 31-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In vivo models in rodents and primates were used to investigate ways of overcoming the poor oral and rectal absorption of ceftriaxone. The sodium salt of ceftriaxone at 20 mg/kg was formulated in C8-C10 chain length, mono- and diglyceride extracts of coconut oil (Capmul) and adminstered intraduodenally to adult rats. Peak plasma levels of 17–52 μg/ml and bioavailability averaging 38% were attained. Significant plasma levels (42–45 μg/ml) were also demonstrated in squirrel monkeys with doses of 20 mg/kg ceftriaxone formulated in Capmul and given by the enteral route. Enteric-coated capsules containing this formulation were also orally administered to squirrel monkeys and gave high plasma levels (10–31 μg/ml) between 1 and 6 h following dosing. In rectal absorption studies, ceftriaxone formulated in Capmul as a suspension gave peak blood levels of 62–84 μg/ml (average bioavailability 42%) in the rabbit. In the baboon, rectal administration of ceftriaxone formulated with Capmul in a Witepsol HI5® suppository gave Cmax levels ranging from 9 to 48 μg/ml, depending on the dose of the antibiotic and the drug/enhancer ratio.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Intestinal AbsorptionAdministration, OralAdministration, RectalAnimalsCeftriaxoneGlyceridesInjections, IntravenousPapioRabbitsRatsRats, Inbred StrainsRectumSaimiri

Substanzen

GlyceridesCeftriaxone

Autor:innen und Institutionen

  • Department of Pharmacology, Hoffmann-La Roche Inc., Nutley, N.J.

Zitieren

APA

Beskid, G., Unowsky, J., Behl, C. R., Siebelist, J., Tossounian, J. L., McGarry, C. M., Shah, N. H., & Cleeland, R. (2009). Enteral, Oral, and Rectal Absorption of Ceftriaxone Using Glyceride Enhancers. Chemotherapy, 77-84. https://doi.org/10.1159/000238551

Vancouver

Beskid G, Unowsky J, Behl CR, Siebelist J, Tossounian JL, McGarry CM, et al. Enteral, Oral, and Rectal Absorption of Ceftriaxone Using Glyceride Enhancers. Chemotherapy. 2009:77-84. doi:10.1159/000238551

BibTeX
@article{Beskid2009,
  author = {Beskid, G and Unowsky, J and Behl, C R and Siebelist, J and Tossounian, J L and McGarry, C M and Shah, N H and Cleeland, R},
  title = {Enteral, Oral, and Rectal Absorption of Ceftriaxone Using Glyceride Enhancers},
  journal = {Chemotherapy},
  year = {2009},
  pages = {77--84},
  doi = {10.1159/000238551}
}
Kostenlos starten →